FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
1-Year Est. Return 44.84%
This Quarter Est. Return
1 Year Est. Return
+44.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$169M
AUM Growth
+$28.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
22
New
Increased
Reduced
Closed

Top Buys

1
+$48.4M
2
+$10.4M
3
+$7.28M
4
NVET
Nexvet Biopharma plc Ordinary Shares
NVET
+$5.69M
5
SGMO icon
Sangamo Therapeutics
SGMO
+$2.59M

Top Sells

1
+$27.8M
2
+$9.71M
3
+$5.29M
4
PRQR icon
ProQR Therapeutics
PRQR
+$3.75M
5
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$3.45M

Sector Composition

1 Healthcare 83.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$56.5M 33.47%
292,621
+250,940
2
$32.9M 19.48%
420,005
+18,238
3
$14.2M 8.4%
754,806
+553,000
4
$7.52M 4.46%
75,000
-96,824
5
$7.28M 4.31%
+3,581
6
$6.58M 3.9%
210,067
-10,000
7
$5.69M 3.37%
+708,332
8
$5.55M 3.29%
91,575
9
$5.55M 3.29%
8,163
-28
10
$5.5M 3.26%
66,295
11
$4.7M 2.79%
447,878
+54,195
12
$4.54M 2.69%
157,131
-87,869
13
$4.26M 2.52%
230
-37
14
$3.62M 2.14%
47
+1
15
$2.59M 1.53%
+165,000
16
$1.84M 1.09%
185,220
-89,780
17
– –
-173,067
18
– –
-144,569
19
– –
0
20
– –
-10,500
21
– –
-3,000,000
22
– –
-106,849